Back to TUDOR INVESTMENT CORP ET AL TUDOR INVESTMENT CORP ET AL

AGNAGN
7 quarters

Position history for TUDOR INVESTMENT CORP ET ALTUDOR INVESTMENT CORP ET AL's holdings in ALLERGAN PLC

As of its Q1 2020 13F, Tudor Investment held 619,565 shares of AGN (Allergan), worth $109.7M. Tudor Investment's 13F filings listed AGN from Q4 2018 to Q1 2020, 6 quarterly filings. AGN was 9.8% of Tudor Investment's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$5.3M

Total Shares Change

-39,772

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q1
Decreased
619,565
-0.1%
$109.7M9.8%—
0
2019-Q4
Increased
620,090
+10.4%
$118.5M5.3%—
65
2019-Q3
Increased
561,500
+112.8%
$94.5M3.2%—
88
2019-Q2
Increased
263,916
+506.8%
$44.2M1.3%—
74
2019-Q1
Increased
43,493
+9.4%
$6.4M0.3%—
36
2018-Q4
First report
39,772
-
$5.3M0.1%—
0

Other major holders of AGN: STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used